Skip to content
2000
Volume 3, Issue 2
  • ISSN: 2213-8099
  • E-ISSN: 2213-8102

Abstract

Recognizing venture capital as a crucial source of funds for life science start-ups, this review paper focuses on the academic literature on venture capitalists’ decision-making process on granting funding to early-stage, high-tech ventures. This review identified the following three issues: First, despite three dominant factors in venture capitalists’ decision-making process, which are identified to be the human, technological and financial aspects of the potential start-up, a great variety of further factors exists and generalization to a great extent is difficult. Secondly, little research has been conducted in Europe and little research employed inductive, qualitative methods. Thirdly, the latest study focusing on a ranking of the importance of decision-making factors for venture capitalists lies 29 years in the past and has been conducted with a North-American sample, leaving a gap for future research in Europe.

Loading

Article metrics loading...

/content/journals/tte/10.2174/2213809903666160519141616
2016-09-01
2025-09-28
Loading full text...

Full text loading...

/content/journals/tte/10.2174/2213809903666160519141616
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test